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Abstract
Background: Although laparoscopic spleen-preserving distal pancreatectomy surgery is more and more
popular, the reports about the en bloc technique used for pancreatic cancer were still rare. The aim of our
study was to illustrate the detail of the spleen-preserving en bloc technique as well as the short-term and
long-term outcomes.
Methods: The detail of the en bloc technique with pictures was described. The prognosis of the successive
23 cases that underwent the laparoscopic distal pancreatectomy (LDP) surgery was evaluated.
Results: There were 17 cases that underwent spleen-preserving LDP while six cases underwent spleen-resecting
LDP. The average surgery time was 203 ± 54 min, and the average blood loss volume was 208 ± 264 ml; one
case transferred to open surgery because of severe adhesion. The complication rate was 47 % (n = 8) shortly
after surgery. Pancreatic fistula rate was 41 % (n = 7). No lethal case occurred. The average diameter of the
tumor was 32 ± 12 mm. The average number of the lymph nodes obtained was 19.8 ± 9.3. All the cutting
edges were negative. Survival rates of the patient after 1, 3, and 5 years are 64.7, 52.9, and 41.2 %, respectively.
These records showed no statistical significance compared with spleen-resecting LDP and open distal pancreatectomy
(ODP) surgeries.
Conclusions: The en bloc spleen-preserving LDP can be performed by experienced surgeons. This surgery has good
short-term and long-term outcomes.
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Background
In the past 20 years, laparoscopic pancreatectomy sur-
gery has been recognized and performed gradually from
diagnostic laparoscopic exploration, specimen biopsy to
distal pancreatectomy, and pancreatoduodenectomy [1].
Because the procedure of laparoscopic distal pancreatec-
tomy (LDP) was not very complex, the number of cases
that underwent this surgery raised quickly for benign
and low-grade malignant disease [2].
Although there were many articles about laparo-
scopic distal pancreatectomy reported [3], the en bloc
concept was rarely mentioned. Many procedures re-
ported [4] only contain the distal pancreatectomy
technique excluding the ganglion resection, lymph
node resection, Gerota fascia removal, and Toldt
fascia removal. These procedures were not suitable for
pancreatic cancer.
Depending on the Japanese General Rules for the
Study of Pancreatic Cancer [5], we designed an en bloc
spleen-preserving LDP procedure which removes the
Gerota fascia, the Toldt fascia, and the distal pancreas as
a whole and resects the 1st and 2nd station lymph nodes
(Table 1). Spleen-preserving LDP against pancreatic
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cancer may be still controversial, and until now, there
has not been any report from a single center about the
long-term prognosis and the standard en bloc LDP pro-
cedure of the surgery. Our aim is to describe the detail
of the standard en bloc technique and to evaluate the
short-term and long-term prognoses compared with the
previous studies [6–10] about open distal pancreatec-
tomy (ODP).
Methods
From the year 2007 to 2010, there were 60 patients who
underwent distal pancreatectomy (DP) surgery. Among
them, 45 cases underwent LDP surgery, 15 cases under-
went ODP surgery, and 23 cases had pancreatic cancer
in the LDP surgery group. Before the year 2002, the indi-
cations of LDP were benign diseases. After 2002, LDP
was indicated both in benign and malignant diseases. All
the patients’ medical records and pathology results were
reviewed.
Ethics, consents, and permissions
The demerits of LDP against pancreatic cancer were the
high requirements of surgical skills and the uncertain
outcomes. The merits of LDP were the micro-invasive
effects leading to fast recovery.
This retrospective study was approved by the Peking
University Ninth School of Clinical Medicine ethics
committee. Patient records were de-identified prior to
analysis. All the patients signed informed consents be-
fore surgery.
The surgical procedure of en bloc LDP
We have three principles in the concept of en bloc
spleen-preserving LDP surgery. First is to dissect from
the Gerota fascia to the Toldt fascia exposing the left
kidney, left renal vein, left adrenal vessels, and left ad-
renal gland. The en bloc technique dissects the Gerota
fascia, Toldt fascia, and distal pancreas. Second is to dis-
sect the lymph nodes and ganglions along the celiac
trunks while resecting the lymph nodes and ganglions
along the superior mesentery artery (SMA). Third is, if
the spleen and the left gastro-epiploic vessels were not
invaded, to dissect the spleen vessels but preserve the
spleen.
The detail of the technique is depicted as follows
(Fig. 1).
The patient was placed in a lithotomic position. We
inserted 10-mm trocars in the umbilicus and right mid-
clavicle line below the costal margin separately, and
double 5-mm trocars in the left upper quadrant of the
abdomen. After dissecting the greater omentum, we
divided the mesocolon transversum from the Gerota
fascia. Then, we identified the inferior border of the
pancreas.
We dissected from the Gerota fascia to the Toldt
fascia exposing the left kidney, left renal vein, left ad-
renal gland, and inferior mesenteric vein (IMV) with
the en bloc method from lateral to medial. We
retracted the pancreas from the dorsal side to the
ventral side. We exposed the junction of the spleen
vein and superior mesentery vein (SMV) from the
dorsal side of the pancreas. We mobilized the SMA
and resected the lymph nodes and celiac ganglion
group II at the left side of the SMA.
We dissected the parenchyma of the pancreas at the
root of the spleen vein. After that, we ligated the spleen
vein and spleen artery at the root. We continued to re-
sect the lymph nodes and celiac ganglion group II at the
left side of the SMA. We preserved the right half of the
celiac ganglion group II at this place. We dissected the
adipose tissue upward to the cephalic side. We exposed
the celiac trunk and resected the lymph nodes and celiac
ganglion group I at root of the celiac trunk. We pre-
served the right half of the celiac ganglion I. Then,
we moved to the left. We skeletonized the left ad-
renal gland and resected the adipose tissue and lymph
nodes around it.
Finally, at the tail of the pancreas, we ligated and dis-
sected the spleen vessels and preserved the gastro-
epiploic vessels and short gastric vessels.
After this procedure, the common hepatic artery, left
gastric artery, celiac trunk, SMA, left adrenal gland and
its vessels, left kidney, and left renal vein are exposed.
The en bloc distal pancreatectomy is finished (Figs. 2
and 3). At last, we closed the pancreatic duct, dislodged
the specimen, and left a drainage tube at the surgical
region.
Data collection and statistical analysis
To analyze the complications after surgery, we adopt
the Clavien-Dindo classification method [11]. To
analyze the pancreatic fistula, we adopt the International
Study Group of Pancreatic Fistula classification method
[12]. The definition of spleen infarction was that the
regional or total spleen is not enhanced by contrast-
enhanced CT. The criteria of discharge were that the
complications of the patient were stabilized, no anal-
gesia was taken, and the patient could accomplish
Table 1 Pancreatic lymph node group in the General Rules for
the Study of Pancreatic Cancer
Pancreatic tail
1st group 8a, 8p, 10, 11p, 11d, 18
2nd group 7, 9, 14p, 14d, 15
3rd group 5, 6, 12a, 12b, 12p, 13a, 13b, 17a, 17b, 16a2, 16b1
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daily activity. The follow-up items after discharge
included routine test, tumor markers (CEA, CA199),
contrast-enhanced CT, or MRI according to the NCCN
guideline [13].
Statistical analysis
Categorical variables were demonstrated as quantity or
percentage. To compare between groups, we use
Fisher’s test or chi-square. Successive variables were
demonstrated as mean ± SD. To compare them, we use
t test. Survival duration started from the date of the
surgery. Recurrence-free survival curve was depicted
by the Kaplan–Meier method. When we evaluated
the recurrence-free survival time, we included the
recurrence-free lethal cases. SPSS (version 19.0.2;
SAS Institute Inc., Cary, NC) software was used in
the statistical analysis.
Results
Among the 23 pancreatic cancer patients who underwent
LDP, 12 were males and 11 were females. Average age was
65 ± 11.4 years. Average BMI was 25.9 ± 4.4 kg/m2.
Anesthesia risk score (ASA score) was 2.2. No pa-
tients underwent neo-chemotherapy before surgery.
The information during the surgery was depicted in
Table 2. There are 17 spleen-preserving LDP cases
and six spleen-resecting LDP cases. Average surgery time
was 203 ± 54 min. Average blood loss was 208 ± 264 ml.
One case converted to ODP because of severe
Fig. 1 The technique of standard en bloc spleen-preserving LDP.
a Dissect the gastro-colic ligament and disconnect the transverse
mesocolon from the Gerota fascia. b At the level above the
upper surface of the pancreas, isolate the left gastro-epiploic
vein (LGEV) and the communicating veins from the distal pancreas.
Preserve the LGEV. c Dissect between the communicating vessels
and the distal pancreas. d At the tail of the pancreas, dissect the
Gerota fascia from the lower border of the left renal vein upward to
the left kidney. e Continue to dissect the Gerota fascia to the left
border of the superior mesentery artery (SMA). Dissect the lymph
nodes and celiac ganglion group II around the SMA preserving the
5-mm ganglion at the right side. f Continue to dissect upward to
the splenic vein. Expose the splenic vein and IMV and ligate and
cut off the IMV. g Penetrate the pancreas from the posterior surface
at the root of the splenic vessels. h Dissect the pancreas at the root
of the splenic vessels with a Harmonic scalpel. i Isolate the splenic
vein at the root and dissect it. j Isolate the splenic artery at the root
and dissect it. k Dissect the lymph nodes and celiac ganglion group
I around the celiac trunk preserving the 5-mm ganglion at the right
side. l Dissect the retroperitoneum adipose tissue at the upper
border of the pancreas. Expose the left adrenal vessels and adrenal
gland. m Preserve the adrenal gland if it has not been invaded.
Dissect the retroperitoneum adipose tissue to the origin. n Ligate
and dissect the spleen vessels at the tail of the pancreas. o Invertedly
suture the stump of the pancreas. p Leave a drainage tube in the
surgical site
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adhesion between the greater omentum, transverse
colon, and intestine. There was no statistical signifi-
cance in surgery time between the spleen-preserving LDP
group and the spleen-resecting LDP group (198 ± 59 vs
223 ± 29 min; P = 0.45). There was no statistical sig-
nificance in blood loss too (184 ± 65 vs 275 ± 109 ml;
P = 0.49).
The complication information was showed in Table 3.
The overall incidence of complication is 48 % (n = 11).
The incidence of pancreatic fistula was 39 % (n = 9).
There was no statistical significance in the complica-
tion rate between the two groups (48 %, n = 8 vs
50 %, n = 3; P = 0.90). All the patients were discharged
within 30 days. There were four cases of grade IIIa
complications. Two cases underwent percutaneous
catheter drainage under the ultrasound scan. Two
cases underwent ERCP to identify the pancreatic
fistula. Three cases were diagnosed with spleen infarc-
tion. Twelve patients were not diagnosed with spleen
infarction. Two patients did not take CT examination
after surgery.
All the patients who suffered from spleen infarction
underwent conservative treatment, and all were cured
without splenectomy. The average length of stay (LOS)
was 17 ± 8 days. There was no statistical significance
between the spleen-preserving and spleen-resecting
LDP groups (18 ± 8 vs 15 ± 7 days; P = 0.36). The
average dimension of the tumor was 32 ± 12 mm. The
average number of lymph nodes that the specimen
contained was 19.8 ± 9.3. There were 14 patients
whose positive lymph node number is ≥1. The path-
ology results were 18 cases of ductal adenocarcinoma,
four cases of intraductal papillary mucinous adenocar-
cinoma, and one case of mucinous adenocarcinoma.
The surgical margins of all the patients were negative.
The final pathology results of the patients were as
follows: two cases of IA stage (8.5 %), five cases of IB
stage (22 %), two cases of IIA stage (8.5 %), 13 cases
of IIB stage (57 %), and one case of III stage (4 %)
(Table 4).
Long-term prognosis
The observation period was 5 years after surgery. The
average survival duration was 19 months. The survival
rates of 1, 3, and 5 years after surgery were 64.7, 52.9,
and 41.2 %, respectively. Six patients suffered from
local recurrence, one suffered from local recurrence
combined with liver metastasis, and two suffered from
retroperitoneal recurrence. The average time to recur-
rence was 14 months. The recurrence-free survival
rates of 1, 3, and 5 years after surgery were 64.7, 47.1,
and 35.3 %, respectively (Fig. 4).
Discussion
In recent studies [14, 15], the efficacy of radical en bloc
LDP is satisfied for treatment of pancreatic cancer in
long-term survival (5-year overall survival was 33 %). It
is acceptable for treating pancreatic cancer. The data of
our research was from a single center. The concept of
en bloc LDP was based on R0 resection and adequate
lymphadenectomy and ganglion resection.
Why do we preserve spleen? Adverse consequences
have been observed after splenectomy. These include a
greater likelihood of postoperative abscesses [16–18]
and, most notably, a long-term risk of serious post-
splenectomy sepsis. The risk of overwhelming post-
splenectomy infection (OPSI) has been estimated to
be 1 per 400–500 patient years and fatal OPSI to be
1 per 800–1000 patient years [19, 20]. While this risk
is greatest in childhood, it persists to a lesser degree
throughout life [21]. In addition, it increases the risk
of later myocardial infarction, diabetes, and even
cancer [22, 23].
How many types of spleen-preserving LDP surgery
are in the world? There are mainly two types. One is
invented by Kimura et al. [24] who performed spleen-
preserving distal pancreatectomy with conservation of
the splenic artery and vein. The advantage of this pro-
cedure was the low occurrence rate of spleen infarc-
tion. The disadvantage was isolating spleen vessels
from the Toldt fascia which did not conform to the en
Fig. 2 The posterior peritoneal structure after dislodging the specimen. a. The stump of the spleen artery, left renal vein, left adrenal vessels, and
SMA was shown in the picture after surgery. b The stump of the spleen vein was shown in the picture
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bloc standards; in other words, this procedure is difficult.
The other procedure was invented by Warshaw [25] who
performed spleen-preserving distal pancreatectomy with
resection of the splenic artery and vein. The blood flow of
the spleen after surgery was compensated by the left
gastro-epiploic vessels and short gastric vessels. Our pro-
cedure is similar with Warshaw’s procedure except for
more extensive retroperitoneal resection, lymphadenec-
tomy, and celiac ganglion resection.
Our study compared with recent studies (Table 5)
shows that the number of lymph nodes obtained by LDP
was similar with that by ODP (19.8 vs 15.5). One hun-
dred percent R0 rate was our most satisfying outcome.
The average dimension of the tumor was similar with
that in ODP (32 vs 33.7 mm) too.
The decrease of blood loss during surgery compared
with ODP (208 vs 747 ml) was mainly due to amplifica-
tion of the view and precise manipulation under the lap-
aroscope as well as the increased abdominal pressure.
The en bloc LDP technique emphasizes resecting the
Gerota fascia, Toldt fascia, and spleen vessels and distal
Table 3 The information after surgery
Clavien-Dindo complication degree
Grade I or II 7 (30 %)
Grade III or IV 4 (17 %)
Pancreatic fistula degree
Overall 9 (39 %)
Grade A 5 (22 %)
Grade B 3 (13 %)
Grade C 1 (4 %)
Operation method
En bloc spleen-resecting LDP (n = 17) 6 (35 %)
En bloc spleen-preserving LDP (n = 6) 3 (50 %)
Pancreas partition method
Harmonic scalpel (n = 20) 7 (35 %)
Ligasure (n = 3) 1 (33 %)
Spleen infarction 3 (18 %)
Mortality rate 0
Length during stay (days) 17 ± 8
Table 2 The information during the surgery
Number of cases
En bloc spleen-preserving LDP 17 (74 %)
En bloc spleen-resecting LDP 6 (26 %)
Surgical time 203 ± 54 min
Blood loss 208 ± 264 ml
Blood transfusion 0
Transfer to ODP 1 (4 %)
Fig. 3 The diagram of en bloc resection range. a After dissecting
the spleen artery and vein, the blood flow of the spleen was
compensated by the left gastro-epiploic vessels and short gastric
vessels. b The Gerota fascia, spleen artery and vein, and distal
pancreas were removed with the en bloc technique. c The
posterior peritoneal structures were shown after the specimen
was removed
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pancreas as a whole to ensure the negative surgical mar-
gin. In contrast, in the standard ODP, it did not need to
remove the Gerota fascia and Toldt fascia routinely. It is
a controversial topic if we should preserve the spleen.
Some study [26] showed that the incidence rate of
spleen infarction was 11 to 29 %. Till now, there has not
been any guideline support that LDP should be com-
bined with splenectomy.
Distal pancreatic cancers sometimes invade to the
lymph nodes and ganglion around the superior mesen-
teric artery. But, totally dissecting the nerve plexus
around the SMA often results in intractable diarrhea
and vomiting. So, we preserved part of the nerve plexus
at the right side of the superior mesenteric artery while
dissecting lymph nodes and ganglions as previously re-
ported [27].
Kim et al. [26] reported that there was a low incidence
rate of lymphatic metastasis at the hilus lienis. Preserv-
ing the spleen can avoid the decrease of immuno-ability
and improve the oncological prognosis. All these reports
[16–23] prompted us to preserve the spleen. Till now,
there has not been any re-operate case because of hilus
lienis lymphatic metastasis.
It was Mitchem et al. [10] who reported that the
average LOS after ODP was 11 ± 7 days. Kooby et al.
[7] reported that the LOS after LDP was 7 ± 3 days.
Because of the different discharge criteria, LOS is dif-
ficult to compare. The main reason for prolonged
LOS is complications (47 %), such as pancreatic fis-
tula (39 %). The optimized operative technique can
reduce the incidence of complication. But, these tech-
niques should also be summarized by a large number
of cases of study.
Fig. 4 The overall survival (OS) and recurrence-free survival (RFS) curve. The observation period was 5 years after surgery. The average survival duration
was 19 months. The survival rates of 1, 3, and 5 years after surgery were 64.7, 52.9, and 47.1 %, respectively. Six patients suffered from local recurrence,
one suffered from local recurrence combined with liver metastasis, and two suffered from retroperitoneal recurrence. The average time to recurrence
was 14 months. The recurrence-free survival rates of 1, 3, and 5 years after surgery were 58.8, 47.1, and 35.3 %, respectively
Table 4 Pathology outcomes
Variables Value, n (%) or mean ± SD
Histologic factors
Tumor size (mm) 32 ± 12 (range, 10–60)
Final histologic diagnosis
Ductal adenocarcinoma 18 (79 %)
Adenocarcinoma associated with IPMC 4 (17 %)
Mucinous cystadenocarcinoma 1 (4 %)
Differentiation
Well 11 (48 %)
Others 12 (52 %)
Harvested LNs 19.8 ± 9.3 (range, 5–40)
Metastatic LNs 2.0 ± 4.1 (range, 0–20)
Surgical margin positive 0
Stage of tumor (UICC classification)
pT1 3 (13 %)
pT2 8 (35 %)
pT3 11 (48 %)
pT4 1 (4 %)
pN0 9 (39 %)
pN1 14 (61 %)
p stage
IA 2 (8.5 %)
IB 5 (22 %)
IIA 2 (8.5 %)
IIB 13 (57 %)
III 1 (4 %)
IPMC intraductal papillary mucinous carcinoma, LN lymph node, UICC Union
for International Cancer Control classification, 7th edition
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In our study, the prognosis of en bloc spleen-preserv-
ing LDP was similar with the previous reports [8, 10,
28, 29]. In these reports, the average overall survival
(OS) was 13 to 26 months, and the 5-year survival
rate was 19–36 %. Till now, based on the reports we
searched, it is the first study about the long-term
prognosis of standard en bloc spleen-preserving LDP.
The limitations of our research were the character of
the retrospective study and the only three types of
pathology results. Randomized controlled trials, a
large number of cases, and long-term trials can avoid
these disadvantages. But because the incidence rate of
distal pancreatic cancer is low, the study is hard to
carry out.
Nevertheless, en bloc LDP preserving the spleen is safe
and effective. The short-term and long-term prognoses
are satisfied which supports this procedure as a treat-
ment for distal pancreatic cancer.
Conclusions
The En-bloc spleen-preserving LDP surgery has good
short-term and long-term outcomes for pancreatic
cancers.
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